Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Sirolimus

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

66 API Suppliers, 31 USDMF, 4 JDMF, 2 EU WC, 3 KDMF, 21 NDC API, 29 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

173 Drugs in Development

173 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers, 25 FDA Orange Book, 32 Europe, 2 Canada, 16 Australia, 31 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 8 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 Kirsch Pharma, 2 Cerata Pharmaceuticals LLP, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 25 BASF, 1 CD Formulation, 11 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 1 Gloria Interchem, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 20 Kerry, 1 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 32 Direct Compression, 29 Solubilizers, 28 Granulation, 27 Thickeners and Stabilizers, 24 Controlled & Modified Release, 23 Disintegrants & Superdisintegrants, 17 Parenteral, 17 Taste Masking, 17 Chewable & Orodispersible Aids, 15 Co-Processed Excipients, 15 Topical, 14 Film Formers & Plasticizers, 12 Lubricants & Glidants, 8 Emulsifying Agents, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 3 Rheology Modifiers, 2 Coloring Agents

DIGITAL CONTENT

90 News #PharmaBuzz

90 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 9 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

22 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 2 US Exclusivities, 12 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
31/03/2026	Curia	U.S.A	CURIA ITALY SRL	21037	SIROLIMUS	2007-11-13	Active	II	N/A
31/03/2026	Chunghwa Chemical Synthesis & Biotech	Taiwan	CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD	17399	RAPAMYCIN	2004-05-20	Active	II	N/A

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Sirolimus

Sirolimus

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

66 API Suppliers

31 USDMF

4 JDMF

2 EU WC

3 KDMF

21 NDC API

29 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

173 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers

25 FDA Orange Book

32 Europe

2 Canada

16 Australia

31 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG

TABLET;ORAL - 1MG

TABLET;ORAL - 2MG

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

8 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 Kirsch Pharma

2 Cerata Pharmaceuticals LLP

2 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

6 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

25 BASF

1 CD Formulation

11 Corel Pharma Chem

4 DFE Pharma

1 Esteem Industries

2 Finar

10 Gangwal Chemicals

1 Gloria Interchem

4 Ideal Cures

1 Ingredion Pharma Solutions

20 Kerry

1 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

2 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

3 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

13 Roquette

13 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

2 Silverline Chemicals

3 The Dow Chemical Company

TABLET;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons